INM

Q: What is the price of InMed Pharmaceuticals (INM) today?

The current price of InMed Pharmaceuticals (INM) is $ 0.73, representing a -75.5% gain over the past year. The stock began the year trading around $ 1.06 and is currently priced at $ 0.73. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does InMed Pharmaceuticals (INM) pay dividends?

InMed Pharmaceuticals (INM) did not pay dividends over the past year.

InMed Pharmaceuticals Inc.

Price

$ 0.73

return (12m)

-75.50%

p/e

-0.40

p/bv

0.32

DIVIDEND YIELD

0.00%

INM price

INM

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment INM

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

11.71%

3 months

-31.53%

1 year

-75.50%

2 years

-84.07%

5 years

-99.96%

10 years

-99.95%

Fundamentals INM

review the fundamentals of InMed Pharmaceuticals shares

P/E

-0.40

Sector: -4.04 Industry: -4.04

P/S (PSR)

0.69

Sector: -3.86 Industry: -3.86

P/BV

0.32

Sector: 1.89 Industry: 1.89

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-68.54%

Sector: -61.23% Industry: -61.23%

ROE

-79.98%

Sector: -60.44% Industry: -60.44%

ROIC

-249.49%

Sector: -1,165.26% Industry: -1,165.26%

NET MARGIN

-100.00%

Sector: -39.16% Industry: -39.16%

GROSS MARGIN

29.78%

Sector: 37.91% Industry: 37.91%

OPERATING MARGIN

-100.00%

Sector: -39.32% Industry: -39.32%

EV/EBITDA

-0.43

Sector: -3.92 Industry: -3.92

EV/EBIT

-0.40

Sector: -4.14 Industry: -4.14

PRICE-TO-ASSETS

0.28

Sector: 1.41 Industry: 1.41

BVPS

2.40

Sector: 1.88 Industry: 1.88

EPS

-1.92

Sector: -2.05 Industry: -2.05

EQUITY-TO-ASSETS RATIO

0.86

Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

0.14

Sector: 0.39 Industry: 0.39

CAGR REVENUE 5 YEARS

4,582.05%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

689.00%

Sector: - Industry: -

Fundamentals INM

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	26.05	6.75	25.92%	2.29%	$ 548.05 B	21.83%
PFE	19.76	1.65	8.35%	6.37%	$ 153.52 B	12.42%
ABBV	83.09	0.00	0.00%	3.35%	$ 351.12 B	6.91%
NVO	11.67	6.01	51.50%	4.53%	$ 182.84 B	33.05%
MRK	15.22	0.00	0.00%	2.97%	$ 277.74 B	28.08%
AZN	28.78	6.04	20.99%	1.69%	$ 294.30 B	17.41%
GILD	19.03	7.16	37.62%	2.45%	$ 161.96 B	28.90%
BMY	16.77	-3.48	-20.72%	4.28%	$ 118.31 B	14.64%
ZTS	19.15	15.37	80.25%	1.74%	$ 51.19 B	28.23%
REGN	17.18	2.48	14.41%	0.48%	$ 77.41 B	31.41%
HALO	24.34	158.01	649.21%	0.00%	$ 7.71 B	22.69%
AMGN	24.08	21.45	89.06%	2.80%	$ 185.71 B	20.98%
MCK	23.47	-1,028.86	-4,383.84%	0.38%	$ 101.86 B	1.09%
VRTX	27.65	5.86	21.18%	0.00%	$ 109.29 B	32.94%
HRMY	11.06	2.02	18.24%	0.00%	$ 1.76 B	18.27%
CAH	28.38	-17.47	-61.56%	1.02%	$ 47.16 B	0.68%
ADMA	18.24	5.61	30.78%	0.00%	$ 2.68 B	28.80%
BIIB	20.96	1.48	7.08%	0.00%	$ 27.10 B	13.07%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

INM Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT InMed Pharmaceuticals

InMed Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (0 people)

United States

45 years

Founded: 1981

Time since IPO - - year

9

Employees

InMed Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $3.09 Millions, with shareholders equity totaling $9.59 Millions.

The company employs approximately 9 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, InMed Pharmaceuticals Inc. reported $4.50 Millions in revenue, generating net income of $-7.67 Millions.

Key financial metrics include a P/E ratio of -0.40, a price-to-book (P/B) ratio of 0.32, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker INM.

Market cap

$ 3.09 Millions

Net worth

$ 9.59 Millions

$ 9,590,000.00

Assets

$ 11.19 Millions

$ 11,190,000.00

Total Shares Outstanding

4.00 Millions

4,000,000

Average Daily Trading Volume

$ 118.45 Thousand

$ 118,453.04

Sector

Health Care

Industry

Biotechnology

INM

INM revenue and profits

Financial Results INM

DRAG THE FRAME TO SEE MORE DATA

INM cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 828.32 18,96% (12M)

P/E

23.47

0.38%

ROE

-4,383.84%

P/BV

-1,028.86

CAH - Cardinal Health

$ 202.34 48,02% (12M)

P/E

28.38

1.02%

ROE

-61.56%

P/BV

-17.47

JNJ - Johnson & Johnson

$ 225.34 49,98% (12M)

P/E

26.05

2.29%

ROE

25.92%

P/BV

6.75

PFE - Pfizer

$ 26.79 26,68% (12M)

P/E

19.76

6.37%

ROE

8.35%

P/BV

1.65

ABBV - AbbVie

$ 197.38 6,86% (12M)

P/E

83.09

3.35%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 110.23 37,32% (12M)

P/E

15.22

2.97%

ROE

0.00%

P/BV

0.00

AZN - AstraZeneca

$ 187.51 33,08% (12M)

P/E

28.78

1.69%

ROE

20.99%

P/BV

6.04

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 828.32 18,96% (12 M)

P/L

23.47

0.38%

ROE

-4,383.84%

P/VP

-1,028.86

CAH - Cardinal Health

$ 202.34 48,02% (12 M)

P/L

28.38

1.02%

ROE

-61.56%

P/VP

-17.47

JNJ - Johnson & Johnson

$ 225.34 49,98% (12 M)

P/L

26.05

2.29%

ROE

25.92%

P/VP

6.75

PFE - Pfizer

$ 26.79 26,68% (12 M)

P/L

19.76

6.37%

ROE

8.35%

P/VP

1.65

ABBV - AbbVie

$ 197.38 6,86% (12 M)

P/L

83.09

3.35%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 110.23 37,32% (12 M)

P/L

15.22

2.97%

ROE

0.00%

P/VP

0.00

AZN - AstraZeneca

$ 187.51 33,08% (12 M)

P/L

28.78

1.69%

ROE

20.99%

P/VP

6.04

Frequently Asked Questions

What is the price of InMed Pharmaceuticals (INM) today?

The current price of InMed Pharmaceuticals (INM) is $ 0.73, representing a -75.5% gain over the past year. The stock began the year trading around $ 1.06 and is currently priced at $ 0.73. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does InMed Pharmaceuticals (INM) pay dividends?

InMed Pharmaceuticals (INM) did not pay dividends over the past year.

Is InMed Pharmaceuticals (INM) a good investment?

InMed Pharmaceuticals (INM) is currently trading at $ 0.73 with a P/E ratio of -0.40%. This represents a -25,001,933% premium compared to its historical average P/E. Over the past year, the stock has gained -75.5 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was -75.50%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy InMed Pharmaceuticals (INM) stock?

You can buy InMed Pharmaceuticals (INM) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol INM and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of InMed Pharmaceuticals (INM) yield today?

Over the past month, InMed Pharmaceuticals (INM) has returned 11.71% — -75.50% over the past year, and -99.96% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of InMed Pharmaceuticals (INM) today at the current price of $ 0.73 your total investment would be $ 73.26.

Based on historical performance, the investment would have grown to approximately:

$ 17.95 after 1 year
$ 0.03 after 5 years
$ 0.04 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

INM

InMed Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment INM

review the fundamentals of InMed Pharmaceuticals shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT InMed Pharmaceuticals

InMed Pharmaceuticals Inc.

United States

45 years

9

PROFIT X PRICE INM

Financial Results INM

INM cash flow

Asset, Revenue and Profit Growth - INM

INM balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

Frequently Asked Questions